Welcome

Dear colleagues,

We warmly invite you to Prague to attend a State-of-the-Art Congress in Gynecologic Oncology, a two-day intensive event featuring:

  • Diagnostics, Surgical treatment, Systemic treatment, Perioperative and Palliative care – presented in four dedicated sections.
  • Current standards in clinical practice – providing the latest evidence-based approaches.
  • Insights into emerging areas – including molecular classification, mechanisms of action of new drugs, and next-generation sequencing.
  • LIVE demonstrations – of ultrasound examinations in patients with ovarian and cervical cancer.
  • VIDEO sessions – with step-by-step guidance on key surgical procedures.

The meeting is designed for all specialists involved in the care of patients with gynecological malignancies.

We look forward to welcoming you to Prague!

David Cibula

 

Preliminary Program

click here

 

Diagnostics and staging

  • Rational use of imaging methods in gynecological oncology
  • Preoperative staging of pelvic masses
  • Assessment of lymph nodes by US, PET and MRI
  • Pelvic side wall anatomy and assessment
  • Imaging guided procedures
  

Perioperative and palliative care

  • Implementation of ERAS and prehabilitation into the routine practice
  • Early palliative care and best supportive care in gynecological oncology
  • Communicating serious news effectively: Tips and tricks for a person-centered approach
  
 

Live ultrasound scanning

LIVE demonstration of ultrasound examination of patients with gynecological tumors.

  

Videosession

Demonstration of main radical surgical procedures step by step.

  
 

Systemic treatment
 

Systemic treatment of ovarian cancer

  • What is BRCA, HRD, HRR, and how they are tested
  • Biomarkers in ovarian cancer – which and when
  • Current SoA chemotherapy
  • Maintenance treatment in 1L and beyond
  

Platinum resistant recurrent ovarian cancer (PROC)

  • Current SoA treatment of PROC
  • What is ADC and how it works
  • Predictive biomarkers and their testing
  • First ADC approved in ovarian cancer in Europe
  • Challenging management of new types of toxicity
  
 

Systemic treatment
 

Management of locally advanced and metastatic cervical cancer

  • Chaos in classification (intermediate/ high risk, IB3, locally advanced disease)
  • What is the current standard treatment in locally advanced cervical cancer (chemoradiotherapy vs induction chemo vs immunotherapy)
  • First line treatment of metastatic disease
  • Tips how to manage toxicity and enhance treatment compliance

Endometrial cancer

  • Molecular classification in endometrial cancer for beginners
  • Indications of adjuvant treatment in the molecular era
  • Systemic treatment of metastatic and recurrent endometrial cancer
  

Immunotherapy and endocrine treatment

  • A guide to cancer immunotherapy
  • Principles of cancer immunotherapy strategies
  • Endocrine treatment in gynaecological tumors
  • The role of NGS and molecular tumor boards in current management
  
 

Surgical treatment
 

Early stages

  • Surgical treatment of non-epithelial and other rare ovarian tumors
  • Surgical treatment of early-stage cervical cancer in the “after SHAPE” era
  • Sentinel lymph nodes in gynecological cancers
  • Management of patients with micrometastases and isolated tumor cells in SLN
  

Fertility sparing treatment

  • Fertility preservation in cervical cancer
  • Fertility preservation in endometrial cancer
  • Management of gynecological tumors in pregnancy
  

Advanced stages

  • Secondary cytoreduction in ovarian and endometrial cancer
  • Pelvic exenterations, LEER and out-of-box procedures
  

 

SAGO 2025 SECRETARIAT
GUARANT International spol. s r.o.
Českomoravská 19, 190 00  Prague 9, Czech Republic
Phone: +420 284 001 444
E-mail: sago-secretariat@guarant.cz | Website: www.guarant.cz